Product news

Share this article:
The FDA has approved Novo Nordisk's PrandiMet, a combination of the insulin secretagogue repaglinide and metformin for the treatment of type 2 diabetes. 
 
Pasteur, the vaccines division of the Sanofi-Aventis Group, announced that the FDA has licensed Pentacel, a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in infants and children 6 weeks through 4 years of age (prior to age 5). 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.